The potential of fluorescein-based Smartprobe imaging in lung cancer has been demonstrated by targeting epidermal growth factor receptor mutations in cell line xenograft mouse model [120] and in ex vivo human lung cancer tissue for visualising matrix activity [118]. This evidence concerns the gene EGFR and lung carcinoma.